EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer
Clinical trial NCT01008475 · COMPLETED
Trial details
- NCT number
- NCT01008475
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.